Future studies are needed to evaluate the effects of treatment with RVT-FxMe on proteins from NO-sGC-cGMP-PDE5 pathway and levels of reactive oxygen species in the penises of SCD and eNOS-/- mice. This evidence concerns the gene SGCB and Schnyder corneal dystrophy.